Skip to main content

Research News

 

Clinical courses

 

Clinical research courses

  • Tau protein can be focal point for future drug therapies in Alzheimers

    Novel discovery has revealed how the tau protein, a critical element in the formation of Alzheimers disease, is also involved in normal learning processes in the healthy brain, potentially providing a focal point for future drug therapies.

    Employing a sensitive method named proximity labelling, the team aimed to identify all proteins that tau comes in contact with within brain cells, labelling and identifying the whole collection of interacting proteins as they went.

  • Future medical applications in drug design Research team studies role morphogens play in tissue patterning in heart development

    Morphogens are molecules that travel from biological cell to cell to pattern tissues in the embryo. These molecules are important not only for the embryo during development, but also for the adult during tissue repair. However, the way these morphogens are distributed to ensure patterning occurs is still not fully understood.

  • A role for cell antennae in managing dopamine signals in the brain

    A historically overlooked rod-like projection present on nearly every cell type in the human body may finally be getting its scientific due: A new study has found that these appendages, called cilia, on neurons in the brain have a key role in ensuring a specific dopamine receptor’s signals are properly received.

  • Body Posture Affects How Oral Drugs Absorbed by Stomach

    A common, economic, and easy method of administering drugs is orally, by swallowing a pill or capsule. But oral administration is the most complex way for the human body to absorb an active pharmaceutical ingredient, because the bioavailability of the drug in the gastrointestinal tract depends on the medication’s ingredients and the stomach’s dynamic physiological environment.

  • Down on Vitamin D? It could be the cause of chronic inflammation

    Inflammation is an essential part of the body's healing process. But when it persists, it can contribute to a wide range of complex diseases including type 2 diabetes, heart disease, and autoimmune diseases.

    Now, world-first genetic research from the University of South Australia shows a direct link between low levels of vitamin D and high levels of inflammation, providing an important biomarker to identify people at higher risk of or severity of chronic illnesses with an inflammatory component.

  • B vitamins can potentially be used to treat advanced non-alcoholic fatty liver disease : Scientists

    Scientists at Duke-NUS Medical School in Singapore have uncovered a mechanism that leads to an advanced form of fatty liver disease—and it turns out that vitamin B12 and folic acid supplements could reverse this process.

    These findings could help people with non-alcoholic fatty liver disease, an umbrella term for a range of liver conditions affecting people who drink little to no alcohol, which affects 25 per cent of all adults globally, and four in 10 adults in Singapore.

  • PvPI reveals new adverse drug reaction of Tacrolimus

    The preliminary analysis of Adverse Drug Reaction (ADR) from the PvPI database reveals that Tacrolimus is associated with Gingival Hypertrophy.

  • Adverse Events after COVID-19 Vaccine in Indian Population

    Medical interns from India studies adverse Events after COVID-19 Vaccine in Indian Population. The study determined the incidence of adverse events experienced by participants post-COVID-19 vaccination and compared adverse events in participants receiving Covishield and Covaxin.

    There are a lot of published studies on the efficacy of these vaccines but little is known about adverse events following vaccination outside of clinical trial data.

  • Pfizer and BioNTech Advance COVID-19 Vaccine Strategy on Enhanced Spike Protein Design

    Pfizer Inc and BioNTech SE announced that the companies have initiated a randomized, active-controlled, observer-blind, Phase 2 study to evaluate the safety, tolerability, and immune response of an enhanced COVID-19 mRNA-based vaccine candidate at a 30 µg dose level. This next-generation bivalent COVID-19 vaccine candidate, BNT162b5, consists of RNAs encoding enhanced prefusion spike proteins for the SARS-CoV-2 ancestral strain (wild-type) and an Omicron variant.

  • Colorectal cancer tumors both helped and hindered by T cells

    Colorectal tumors are swarming with white blood cells, but whether these cells help or hinder the cancer is hotly debated. While some studies have shown that white blood cells heroically restrict tumor growth and combat colorectal cancer, equally compelling evidence casts the white blood cells as malignant co-conspirators bolstering the tumor and helping it spread.

Subscribe to Research News